Bionano Genomics BNGO Cash Flow Statement (2017-2026)

NASDAQ BNGO
$1.25 +0.02 (+2.05%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Bionano Genomics Quarterly Cash Flow Statement

Periods 36 quarters
Latest Jun 2026

Bionano Genomics reported cash from operations of -$4.68M and free cash flow of -$4.68M for the quarter ended Jun 2026, down 34.3% year over year. This cash flow statement covers 36 quarters of results from Sep 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-20.75M-22.95M-29.95M-32.16M-31.81M-38.68M-37.12M-38.91M-112.57M-43.89M-31.42M-16.22M-44.25M-20.13M-3.10M-6.86M-8.50M-7.93M-8.30M-7.42M
Depreciation and DepletionDep. & Depletion
-0.50M5.40M1.10M1.00M1.00M1.00M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.02M0.03M0.09M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M
Depreciation & Amortization (CF)Dep. & Amort.
0.53M1.86M2.21M2.27M2.38M2.77M3.19M3.30M3.63M3.60M3.01M2.99M5.63M2.40M2.43M2.38M2.38M2.34M2.31M2.30M
Share-based CompensationStock Comp.
2.79M4.80M5.10M5.78M6.06M5.48M3.88M3.93M3.99M3.37M3.02M2.58M2.20M1.94M1.59M1.08M0.94M0.93M0.67M0.97M
Gains from Sales and DivestituresGains Divest
-0.30M-0.10M-1.40M-0.02M-0.28M-0.03M
Gains from Investment SecuritiesGains Investment
-0.07M-0.01M-0.02M0.00M-0.02M0.00M
Asset Writedowns and ImpairmentWritedown
77.30M0.45M7.20M
Other non-cash itemsOther Non-Cash
-0.92M0.38M0.25M0.90M14.86M-0.10M-2.08M0.12M-0.28M-0.08M0.12M-0.01M
Change in Working Capital
Change in ReceivablesChange Receivables
0.27M0.16M0.64M-0.66M1.16M1.12M-0.24M0.83M1.06M0.65M-1.00M-2.06M-0.94M-0.13M-1.40M0.14M1.03M0.67M-1.07M0.23M
Change in InventoryChange Inventory
6.74M5.58M5.94M6.16M6.03M5.56M5.71M1.64M-3.53M0.33M0.20M0.87M2.45M-2.93M-1.11M-0.72M-1.51M-1.57M0.11M-0.08M
Change in Account PayablesChange Payables
4.13M1.84M-3.17M1.10M0.84M3.18M3.02M-3.81M3.19M-4.40M-0.54M-1.11M-0.03M-1.74M-0.40M-0.32M-0.25M-0.40M-0.53M-0.50M
Change in Accured ExpensesChange Accured Exp.
3.02M-0.15M-0.44M-1.03M3.54M-1.70M-0.98M-1.09M3.04M-3.49M3.17M-5.25M0.39M-0.55M-0.49M-1.34M0.72M0.52M-1.42M-0.55M
Change in Other Operating AssetsOther Assets Change
2.47M-0.10M0.37M-0.56M3.63M0.89M-0.10M-1.10M7.62M-2.62M-1.86M-0.82M-2.34M-1.25M-0.40M-0.31M1.95M0.76M-0.36M-0.55M
Other Working Capital ChangesOther WC Changes
-2.47M0.10M-0.37M0.56M-3.63M-0.89M0.10M1.10M-7.62M2.62M1.86M0.82M2.34M1.25M0.40M0.31M-1.95M-0.76M0.36M0.55M
Cash from OperationsCash from Ops.
-19.98M-25.62M-32.49M-28.33M-29.47M-34.52M-32.41M-36.70M-26.29M-29.78M-28.13M-20.98M-13.31M-6.50M-2.76M-3.49M-5.95M-4.15M-5.72M-4.68M
Investing Activities
Capital ExpendituresCapex
0.27M1.12M0.98M0.47M0.29M1.46M0.36M0.51M0.08M0.75M0.03M0.08M
Sales of Property, Plant and EquipmentPP&E (Sale)
-0.13M0.03M0.00M
Change in Property, Plant and EquipmentChange in PP&E
-0.27M-1.24M-0.96M-0.47M-0.29M-1.46M-0.36M-0.51M-0.08M-0.75M-0.03M-0.08M
Acquisitions
49.09M-0.69M32.04M
Net of Acquisitions & DivestmentsNet Acquisitions
-49.09M0.69M-32.04M
Purchase of InvestmentsInvestments Purchased
205.33M108.06M14.95M14.59M33.67M20.99M4.49M106.78M110.56M41.03M62.74M18.70M64.77M51.88M60.89M64.35M48.67M31.46M
Sale and Maturity of InvestmentsInvestments Sold
20.00M66.50M94.36M92.59M83.82M65.50M16.89M29.99M37.99M52.15M158.17M69.74M57.36M21.70M50.70M53.85M56.22M68.36M54.13M45.14M
Cash from Investing ActivitiesCash from Investing
-185.60M-92.51M31.96M31.24M7.95M11.61M16.53M29.58M33.43M-55.37M47.59M28.63M-5.38M3.00M-14.07M1.98M-4.67M4.01M5.46M13.68M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
80.00M
Long-Term Debt RepaymentsLT Debt Repayment
-2.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M9.01M36.68M25.80M1.57M2.01M1.52M1.52M1.89M0.02M0.02M10.29M
Non-Current Debt
2.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M70.99M-36.68M-25.80M-1.57M-2.01M-1.52M-1.52M-1.89M-0.02M-0.02M-10.29M
Short-Term Debt issuancesST Debt Issuance
Short-Term Debt repaymentsST Debt Repayment
Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
2.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M70.99M-36.68M-25.80M-1.57M-2.01M-1.52M-1.52M-1.89M-0.02M-0.02M-10.29M
Change in Capital Stock
Common Stock IssuedStock Issued
14.32M-0.13M0.02M0.14M23.24M0.08M15.25M18.35M12.92M11.30M15.45M12.17M10.11M6.72M13.33M3.09M12.94M1.75M0.71M0.62M
Net Shares Issued and RepurchasedNet Shares Issued
14.32M-0.13M0.02M0.14M23.24M0.08M15.25M18.35M12.92M11.30M15.45M12.17M10.11M6.72M13.33M3.09M12.94M1.75M0.71M0.62M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
14.32M-0.13M0.02M0.14M23.24M0.08M15.25M18.35M12.92M11.30M15.45M12.17M10.11M6.72M13.33M3.09M12.94M1.75M0.71M0.62M
Other financing activitiesOther financing
-0.56M-0.58M-0.38M-0.46M-0.32M-13.80M-0.39M-6.35M-2.52M-0.82M-0.92M-0.10M-0.97M-0.13M-0.03M-0.03M
Cash from Financing ActivitiesCash from Financing
13.77M1.97M0.01M0.20M22.65M0.15M14.86M17.88M12.59M68.48M-21.62M-1.98M6.02M3.89M10.89M1.47M10.08M1.60M0.66M-9.69M
Additional items
Exchange Rate EffectFX Effect
-0.12M0.09M0.04M-0.01M-0.01M0.05M-0.03M0.00M0.02M0.00M-0.01M-0.02M0.02M0.01M0.01M0.00M
Change in Cash
-191.82M-116.17M-0.52M3.11M1.01M-22.68M-0.99M10.75M19.71M-16.62M-2.19M5.67M-12.64M0.38M-5.95M-0.06M-0.50M1.44M0.40M-0.68M
Ending Cash Balance
140.74M24.57M24.05M27.16M28.17M5.49M4.50M15.26M34.97M18.35M16.16M21.83M9.19M9.57M3.63M3.56M3.10M4.51M4.91M4.23M
Free Cash FlowFCF
-20.25M-26.74M-33.48M-28.80M-29.76M-35.98M-32.77M-37.21M-26.37M-30.52M-28.16M-21.06M-13.31M-6.50M-2.76M-3.49M-5.95M-4.15M-5.72M-4.68M
Net Cash FlowNCF
-191.82M-116.17M-0.52M3.11M1.13M-22.76M-1.02M10.76M19.72M-16.67M-2.16M5.68M-12.66M0.38M-5.94M-0.04M-0.54M1.47M0.40M-0.70M
Interest Paid
0.00M1.42M0.07M0.07M0.08M0.08M0.08M0.07M0.07M1.43M5.62M4.05M0.47M0.52M0.48M0.44M0.39M0.36M0.36M0.25M

Bionano Genomics Cash Flow Statement API

Pull Bionano Genomics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BNGO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY